Opening Summary
FTC action led Alcon to abandon its proposed acquisition of LensAR, avoiding a deal the agency said would raise prices and reduce innovation in cataract laser surgery systems.
What Happened
According to FTC on March 17, 2026 in Federal — FTC, FTC action led Alcon to abandon its proposed acquisition of LensAR, avoiding a deal the agency said would raise prices and reduce innovation in cataract laser surgery systems. The primary source is linked in the Source section below; readers are encouraged to review it directly for full context.
Why This Is Trending Now
The action underscores continued FTC willingness to challenge concentrated healthcare device markets.
Why Businesses Should Pay Attention
Health-tech and device dealmakers must build antitrust risk into deal timelines and pricing.
Practical Considerations
Businesses may want to monitor the status of the underlying rule, filing, proceeding, or announcement as it evolves. Companies may need to evaluate how this development could interact with current contracts, licenses, disclosures, and compliance programs. The issue may raise questions around vendor obligations, reporting timelines, and internal policy updates that warrant discussion with qualified counsel.
Cogent Law Perspective
Cogent Law counsels dealmakers on antitrust risk, HSR strategy, and remedies. The best next step is to speak with counsel about the facts specific to your organization.
Key Takeaways
- The action underscores continued FTC willingness to challenge concentrated healthcare device markets.
- Health-tech and device dealmakers must build antitrust risk into deal timelines and pricing.
- Cogent Law counsels dealmakers on antitrust risk, HSR strategy, and remedies.
- Review the primary source from FTC for the full record before making any decisions.
- Speak with Cogent Law to discuss how this development may affect your business.
Related Practice Areas
Corporate and M&A
Formation, governance, financings, and M&A across regulated industries.
Learn MoreLitigation & Dispute Resolution
Commercial litigation, regulatory enforcement, and dispute resolution.
Learn MoreTalk to Cogent Law
Have questions about how this update may affect your business?
Stress-test your deal antitrust risk with Cogent Law.
Legal Disclaimer
This update is provided for general informational purposes only and does not constitute legal advice. Reading this update does not create an attorney-client relationship. For advice regarding a specific matter, please contact Cogent Law.
